OverviewSuggest Edit

Atomwise uses Deep Learning Neural Networks to help discover new medicines. Atomwise achieves the world’s best results for new drug hit discovery, binding affinity prediction, and toxicity detection. Atomwise predicts drug candidates for pharmaceutical companies, startups, and research institutions. The Company's tools can tell the difference between great drug candidates and toxic ones, and discover new uses for old medicines.

... Show more
TypePrivate
Founded2012
HQSan Francisco, US
Websiteatomwise.com

Latest Updates

Employees (est.) (Feb 2019)33(+7%)

Key People/Management at Atomwise

Bastiaan Bergman

Bastiaan Bergman

Senior Machine Learning Engineer
Han Lim

Han Lim

VP and Global Head of Partnering
Michael Mysinger

Michael Mysinger

Principal Scientist
Abraham Heifets

Abraham Heifets

CEO, Co-Founder
Jeff Warrington

Jeff Warrington

Senior Scientist
Stefan Schrödl

Stefan Schrödl

Principal Machine Learning Scientist
Show more

Atomwise Office Locations

Atomwise has an office in San Francisco
Show all (1)
Report incorrect company information

Atomwise Financials and Metrics

Summary Metrics

Atomwise's latest funding round in March 2018 was reported to be $45 m. In total, Atomwise has raised $51.6 m
View all funding rounds
Report incorrect company information

Atomwise Online and Social Media Presence

Embed Graph
Report incorrect company information

Atomwise News and Updates

The key factor is driving the Global Artificial Intelligence In Life Sciences Market 2023 Overview, Analysis and Trends, top key players - IBM Corporation, AiCure, LLC, NuMedii, twoXAR, Atomwise Inc, Lifegraph Limited, Cyrcadia Health and others

Global Artificial Intelligence In Life Sciences Market Trends, Drivers, Strategies, Segmentation Application, Technology & Market Analysis Research Report to 2023 Posted via Industry Today. Follow us on Twitter @IndustryToday

Healthcare Artificial Intelligence Market Competitive Scenario of Leading Key Players 2017 and 2022 | IBM Watson Health, AiCure, Atomwise, Cyrcadia Health, Lifegraph, Modernizing Medicine, Sensely, Zebra Medical Vision, Sophia Genetics, iCarbonX, Welltok,

Worldwide Market Reports has announced the addition of the “Global Healthcare Artificial Intelligence Market Size, Status and Forecast 2022”,, Report offering you more creative solutions that combine our deep geographic experience, intimate sector knowledge and clear insights into how to create valu…
Report incorrect company information

Atomwise Blogs

Charles River Laboratories and Atomwise Form a Strategic Alliance to Provide Integrated, Artificial Intelligence-Driven Drug Discovery

Charles River reaffirms commitment to the future of drug discovery by advancing the Company’s integrated, innovative early-stage platform   WILMINGTON, Mass., and SAN FRANCISCO, Calif., January 11, 2019 – Charles River Laboratories International, Inc. (NYSE: CRL) and Atomwise, Inc. today announced t…

Atomwise and Charles River Laboratories Form a Strategic Alliance to Provide Premier Artificial Intelligence-Powered Drug Discovery Capabilities

Charles River’s clients gain access to Atomwise’s Artificial Intelligence (AI) technology to improve novelty, quality and efficiency of preclinical drug discovery. January 11, 2019. SAN FRANCISCO: Atomwise, Inc. today announced a strategic alliance with Charles River Laboratories International, Inc.…

Atomwise Enters into an Evaluation Agreement with Pfizer

Atomwise Inc., a leader in Artificial Intelligence (AI) for drug discovery and design, has entered into an evaluation agreement with Pfizer Inc. (NYSE: PFE). Pfizer will evaluate Atomwise’s platform to identify potential drug candidates for up to three target proteins selected by Pfizer. In the agre…

Atomwise Expands its Groundbreaking Artificial Intelligence Screening Program to Support Academic Projects Worldwide

Following a successful first year supporting 100 pioneering research projects, Atomwise opens a new round of awards to academic researchers. Atomwise Inc., a leader in using Artificial Intelligence (AI) for drug screening and design, has announced that 100 academic projects have received an Artifici…

Atomwise Company Life and Culture

Report incorrect company information

Atomwise Frequently Asked Questions

  • When was Atomwise founded?

    Atomwise was founded in 2012.

  • Who are Atomwise key executives?

    Atomwise's key executives are Bastiaan Bergman, Han Lim and Michael Mysinger.

  • How many employees does Atomwise have?

    Atomwise has 33 employees.

  • Who are Atomwise competitors?

    Competitors of Atomwise include BioXcel Therapeutics, Perrigo and Horizon Pharma.

  • Where are Atomwise offices?

    Atomwise has an office in San Francisco.

  • How many offices does Atomwise have?

    Atomwise has 1 office.